Perioperative use of selective alpha-2 agonists and antagonists in small animals

Canadian Veterinary Journal

Volumn 45, Issue 6, 2004, Pages 475-480

  Lemke, Kip A ^a  

^a UNIVERSITY OF PRINCE EDWARD ISLAND   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACEPROMAZINE; ALPHA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; ATIPAMEZOLE; ATROPINE; BUTORPHANOL; CHOLINERGIC RECEPTOR BLOCKING AGENT; CLONIDINE; DEXMEDETOMIDINE; GLYCOPYRRONIUM BROMIDE; HYDROMORPHONE; ISOFLURANE; KETAMINE; MEDETOMIDINE; MORPHINE; OPIATE; OXYMORPHONE; ROMIFIDINE; XYLAZINE; YOHIMBINE;

ANALGESIA; ANALGESIC ACTIVITY; ANESTHESIA; ANESTHESIA INDUCTION; ANTICHOLINERGIC EFFECT; CARDIOVASCULAR EFFECT; CAT; DOG; DOSE CALCULATION; DOSE TIME EFFECT RELATION; DRUG ABSORPTION; DRUG ANTAGONISM; DRUG APPROVAL; DRUG ELIMINATION; DRUG HALF LIFE; DRUG POTENCY; DRUG POTENTIATION; DRUG RECEPTOR BINDING; DRUG SELECTIVITY; GASTROINTESTINAL MOTILITY; LOW DRUG DOSE; MUSCLE RELAXATION; NONHUMAN; PERIOPERATIVE PERIOD; POSTOPERATIVE ANALGESIA; PREOPERATIVE PERIOD; RESPIRATION DEPRESSION; REVIEW; SEDATION; VETERINARY MEDICINE;

ADRENERGIC ALPHA-AGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANESTHESIA; ANESTHETICS, COMBINED; ANIMALS; CATS; DOGS; PERIOPERATIVE CARE; RECEPTORS, ADRENERGIC, ALPHA-2;

ANIMALIA; CANIS FAMILIARIS; FELIS CATUS;

EID: 3242763047     PISSN: 00085286     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (65)

1. Greene SA, Thurmon JC. Xylazine - a review of its pharmacology and use in veterinary medicine. J Vet Pharmacol Ther 1988;11: 295-313.
2. Cullen LK. Medetomidine sedation in dogs and cats: a review of its pharmacology, antagonism and dose. Br Vet J 1996;152:519-535.
3. Paddleford RR, Harvey RC. Alpha-2 agonists and antagonists. Vet Clin North Am Small Anim Pract 1999;29:737-745.
4. Tranquilli WJ, Benson GJ. Advantages and guidelines for using alpha-2 agonists as anesthetic adjuvants. Vet Clin North Am Small Anim Pract 1992;22:289-293.
5. Klide AM. Precautions when using alpha-2 agonists as anesthetics or anesthetic adjuvants. Vet Clin North Am Small Anim Pract 1992;22:294-296.
6. Bergstrom K. Cardiovascular and pulmonary effects of a new sedative/analgesic (medetomidine) as a preanaesthetic drug in the dog. Acta Vet Scand 1988;29:109-116.
7. Cullen LK, Reynoldson JA. Xylazine or medetomidine premedication before propofol anaesthesia. Vet Rec 1993;132:378-383.
8. Ewing KK, Mohammed HO, Scarlett JM, et al. Reduction of isoflurane anesthetic requirement by medetomidine and its restoration by atipamezole in dogs. Am J Vet Res 1993;54:294-299.
9. Steffy EP. Inhalation anesthetics. In: Thurmon JC, Tranquilli WJ, Benson GJ, eds. Lumb and Jones' Veterinary Anesthesia. Philadephia: Lippincott Williams & Wilkins, 1996;297-329.
10. Lemke KA, Tranquilli WJ, Thurmon JC, et al. Hemodynamic effects of atropine and glycopyrrolate in isoflurane-xylazine-anesthetized dogs. Vet Surg 1993;22:163-169.
11. Keegan RD, Greene SA, Bagley RS, et al. Effects of medetomidine administration on intracranial pressure and cardiovascular variables of isoflurane-anesthetized dogs. Am J Vet Res 1995;56: 193-198.
12. Bostrom I, Nyman G, Kampa N, et al. Effects of acepromazine on renal function in anesthetized dogs. Am J Vet Res 2003;64:590-598.
13. Gaynor JS, Dunlop CI, Wagner AE, et al. Complications and mortality associated with anesthesia in dogs and cats. J Am Anim Hosp Assoc 1999;35:13-17.
14. Mazzaferro E, Wagner AE. Hypotension during anesthesia in dogs and cats: recognition, causes, and treatment. Compend Contin Educ Pract Vet 2001;23:728-737.
15. Lemke KA, Tranquilli WJ. Anesthetics, arrhythmias, and myocardial sensitization to epinephrine. J Am Vet Med Assoc 1994;205: 1679-1684.
16. Muir WW, Werner LL, Hamlin RL. Effects of xylazine and acetylpromazine upon induced ventricular fibrillation in dogs anesthetized with thiamylal and halothane. Am J Vet Res 1975;36:1299-1303.
17. Tranquilli WJ, Thurmon JC, Benson GJ. Alterations in epinephrine-induced arrhythmogenesis after xylazine and subsequent yohimbine administration in isoflurane-anesthetized dogs. Am J Vet Res 1988;49:1072-1075.
18. Lemke KA, Tranquilli WJ, Thurmon JC, et al. Alterations in the arrhythmogenic dose of epinephrine after xylazine or medetomidine administration in halothane-anesthetized dogs. Am J Vet Res 1993;54:2132-2138.
19. Lemke KA, Tranquilli WJ, Thurmon JC, et al. Alterations in the arrhythmogenic dose of epinephrine after xylazine or medetomidine administration in isoflurane-anesthetized dogs. Am J Vet Res 1993;54:2139-2144.
20. Pettifer GR, Dyson DH, McDonell WN. An evaluation of the influence of medetomidine hydrochloride and atipamezole hydrochloride on the arrhythmogenic dose of epinephrine in dogs during halothane anesthesia. Can J Vet Res 1996;60:1-6.
21. Dyson D, Pettifer G. Evaluation of the arrhythmogenicity of a low dose of acepromazine: comparison with xylazine. Can J Vet Res 1997;61:241-245.
22. Hayashi Y, Sumikawa K, Maze M, et al. Dexmedetomidine prevents epinephrine-induced arrhythmias through stimulation of central alpha-2 adrenoceptors in halothane-anesthetized dogs. Anesthesiology 1991;75:113-117.
23. Dyson DH, Maxie MG, Schnurr D. Morbidity and mortality associated with anesthetic management in small animal veterinary practice in Ontario. J Am Anim Hosp Assoc 1998;34:325-335.
24. Lemke KA. Understanding the pathophysiology of perioperative pain. Can Vet J 2004;45:405-413.
25. Maze M, Tranquilli W. Alpha-2 adrenoceptor agonists: defining the role in clinical anesthesia. Anesthesiology 1991;74:581-605.
26. Maze M, Fujinaga M. Alpha-2 adrenoceptors in pain modulation: which subtype should be targeted to produce analgesia? Anesthesiology 2000;92:934-936.
27. Pypendop BH, Verstegen JP. Hemodynamic effects of medetomidine in the dog: a dose titration study. Vet Surg 1998;27:612-622.
28. Lemke KA. Sedative effects of intramuscular administration of a low dose of romifidine in dogs. Am J Vet Res 1999;60:162-168.
29. Pypendop BH, Verstegen JP. Cardiovascular effects of romifidine in dogs. Am J Vet Res 2001;62:490-495.
30. Klide AM, Calderwood HW, Soma LR. Cardiopulmonary effects of xylazine in dogs. Am J Vet Res 1975;36:931-935.
31. Lawrence CJ, Prinzen FW, de Lange S. The effect of dexmedetomidine on nutrient organ blood flow. Anesth Analg 1996;83: 1160-1165.
32. Haskins SC, Peiffer RL Jr, Stowe CM. A clinical comparison of CT1341, ketamine, and xylazine in cats. Am J Vet Res 1975;36: 1537-1543.
33. Alibhai HI, Clarke KW, Lee YH, et al. Cardiopulmonary effects of combinations of medetomidine hydrochloride and atropine sulphate in dogs. Vet Rec 1996;138:11-13.
34. Bloor BC, Abdul-Rasool I, Temp J, et al. The effects of medetomidine, an alpha-2 adrenergic agonist, on ventilatory drive in the dog. Acta Vet Scand Suppl 1989;85:65-70.
35. Lemke KA. Electrocardiographic and cardiopulmonary effects of intramuscular administration of glycopyrrolate and romifidine in conscious beagle dogs. Vet Anesth Analg 2001;28:75-86.
36. Celly CS, Atwal OS, McDonell WN, et al. Histopathologic alterations induced in the lungs of sheep by use of alpha-2 adrenergic receptor agonists. Am J Vet Res 1999;60:154-161.
37. Benson GJ, Thurmon JC, Neff-Davis CA. Effect of xylazine hydrochloride upon plasma glucose and serum insulin concentrations in adult pointer dogs. J Am Anim Hosp Assoc 1984;20: 791-794.
38. Burton SA, Lemke KA, Ihle SL, et al. Effects of medetomidine on serum insulin and plasma glucose concentrations in clinically normal dogs. Am J Vet Res 1997;58:1440-1442.
39. Burton S, Lemke KA, Ihle SL, et al. Effects of medetomidine on serum osmolality; urine volume, osmolality and pH; free water clearance; and fractional clearance of sodium, chloride, potassium, and glucose in dogs. Am J Vet Res 1998;59:756-761.
40. Gellai M, Edwards RM. Mechanism of alpha-2 adrenoceptor agonist-induced diuresis. Am J Physiol 1988;255:317-323.
41. Rouch AJ, Kudo LH, Hebert C. Dexmedetomidine inhibits osmotic water permeability in the rat cortical collecting duct. J Pharmacol Exp Ther 1997;281:62-69.
42. Vaha-Vahe T. Clinical evaluation of medetomidine, a novel sedative and analgesic drug for dogs and cats. Acta Vet Scand 1989;30: 267-273.
43. Ansah OB, Raekallio M, Vainio O. Comparison of three doses of dexmedetomidine with medetomidine in cats following intramuscular administration. J Vet Pharmacol Ther 1998;21:380-387.
44. Lamont LA, Bulmer BJ, Grimm KA, et al. Cardiopulmonary evaluation of the use of medetomidine hydrochloride in cats. Am J Vet Res 2001;62:1745-1749.
45. England GC, Flack TE, Hollingworth E, et al. Sedative effects of romifidine in the dog. J Small Anim Pract 1996;37:19-25.
46. England GC, Watts N. Effect of romifidine and romifidine-butorphanol for sedation in dogs. J Small Anim Pract 1997;38: 561-564.
47. Selmi AL, Barbudo-Selmi GR, Moreira CF, et al. Evaluation of sedative and cardiorespiratory effects of romifidine and romifidine-butorphanol in cats. J Am Vet Med Assoc 2002;221:506-510.
48. Virtanen R. Pharmacological profiles of medetomidine and its antagonist, atipamezole. Acta Vet Scand Suppl 1989;85:29-37.
49. Salonen JS. Pharmacokinetics of medetomidine. Acta Vet Scand Suppl 1989;85:49-54.
50. Vainio O. Introduction to the clinical pharmacology of medetomidine. Acta Vet Scand Suppl 1989;85:85-88.
51. 2O anesthesia in dogs. Can J Vet Res 1999; 63:31-36.
52. Vainio O, Vaha-Vahe T, Palmu L. Sedative and analgesic effects of medetomidine in dogs. J Vet Pharmacol Ther 1989;12:225-231.
53. Muir WW, III, Ford JL, Karpa GE, et al. Effects of intramuscular administration of low doses of medetomidine and medetomidine-butorphanol in middle-aged and old dogs. J Am Vet Med Assoc 1999;215:1116-1120.
54. Ansah OB, Vainio O, Hellsten C, et al. Postoperative pain control in cats: clinical trials with medetomidine and butorphanol. Vet Surg 2002;31:99-103.
55. Vaha-Vahe AT. The clinical effectiveness of atipamezole as a medetomidine antagonist in the dog. J Vet Pharmacol Ther 1990;13: 198-205.
56. Vaha-Vahe AT. Clinical effectiveness of atipamezole as a medetomidine antagonist in cats. J Small Anim Pract 1990;1:193-197.
57. Benson GJ, Grubb TL, Neff-Davis C, et al. Perioperative stress response in the dog: effect of pre-emptive administration of medetomidine. Vet Surg 2000;29:85-91.
58. Ko JC, Mandsager RE, Lange DN, et al. Cardiorespiratory responses and plasma cortisol concentrations in dogs treated with medetomidine before undergoing ovariohysterectomy. J Am Vet Med Assoc 2000;217:509-514.
59. Vaisanen M, Raekallio M, Kuusela E, et al. Evaluation of the perioperative stress response in dogs administered medetomidine or acepromazine as part of the preanesthetic medication. Am J Vet Res 2002;63:969-975.
60. Short CE. Effects of anticholinergic treatment on the cardiac and respiratory systems in dogs sedated with medetomidine. Vet Rec 1991;129:310-313.
61. Ko JC, Fox SM, Mandsager RE. Effects of preemptive atropine administration on incidence of medetomidine-induced bradycardia in dogs. J Am Vet Med Assoc 2001;218:52-58.
62. Sinclair MD, McDonell WN, O'Grady MR, et al. The cardiopulmonary effect of romifidine in dogs with or without prior or concurrent administration of glycopyrrolate. Vet Anesth Analg 2002;29:1-13.
63. Vainio O, Palmu L. Cardiovascular and respiratory effects of medetomidine in dogs and influence of anticholinergics. Acta Vet Scand 1989;30:401-408.
64. Magoon KE, Hsu WH, Hembrough FB. The influence of atropine on the cardiopulmonary effects of a xylazine-ketamine combination in dogs. Arch Int Pharmacodyn Ther 1988;293:143-153.
65. van der Linde-Sipman JS, Hellebrekers LJ, Lagerwey E. Myocardial damage in cats that died after anaesthesia. Vet Q 1992;15:91-94.